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ABSTRACT

KEYWORDS

Pharmaceuticals having the hydrazide functional group are an important
division within anti-tuberculosis, anti-parasitic, anti-cancer, and anti-radiation chemotherapeutics. This work presents a colorimetric methodology to
detect and quantify hydrazide based pharmaceuticals. Processes for rapid
spot test, qualitative colorimetric assay, and spectrophotometric quantitative assay are presented. The reagent 2,6-dichloroquinone-4-chloroimine
(Gibb’s reagent) is utilized to accomplish the various analytical objectives.
The rapid spot test and qualitative colorimetric assay enables a detection of
hydrazide drugs to a level of 0.0037 grams per milliliter. Quantitative spectrophotometric detection of hydrazide drugs is sensitive to a level of 128.2
micrograms per milliliter. The molar absorptivity () is calculated to be 25.32
Liters/(molecm) at 970nm. Inorganic salts and organic compounds were
found not to interfere with colorimetric detection of hydrazide drugs, and
this includes NaBr, NaCl, MgSO4, 2-naphthol, benzoin, p-aminobenzoic acid
various other compounds. Reagents necessary for this methodological
approach are readily available. The colorimetric response of these tests is
readily identified by visual inspection. These methods then are highly sensitive and provide a manner to determine this important type of drugs from
environmental as well as biological origins.
2010 Trade Science Inc. - INDIA

INTRODUCTION
Hydrazide based pharmaceuticals (have the hydrazide functional group located on the molecular structure) are an important group of diversified chemo-therapeutics. Examples of this important category of drugs
come from medical areas of anti-tuberculosis, anti-para-

Hydrazide;
Isoniazid;
Colorimetric;
Gibb’s reaction.

sitic, anti-cancer, and anti-radiation clinical therapeutics. One example that is credited as saving many lives
is isoniazid, a first-line medication/treatment for the bactericidal/bacteriostatic inhibition of tuberculosis[1-3]. Acyl
hydrazides have shown substantial potential for important anti-trypanosomal chemotherapeutic agents including the treatment for parasitic protist Trypanosoma
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Figure 1 : Molecular structures of pharmaceuticals utilized in this work are presented having hydrazide functional groups.
The hydrazide functional group is indicated by inset rectangle. Drugs A, B, C, and D were synthesized utilizing microwave
methodology while semicarbazide was used in this study as the spectrophotometric standard.

Positive
Negative
Figure 2 : A rapid spot test result demonstrating the use of
Gibb’s reagent detection of hydrazide functional groups. Left
tube is “positive” reaction for the presence of hydrazide drug
(2 milligrams), right side is negative colorimetric response
(no hydrazide drug).

brucei or African Sleeping Sickness[4]. Previous studies
of hydrazide derivatives of wild garlic result in compounds that could function as effective anti-genotoxic
chemotherapeutics for inhibition of clastogenic (mutagenic breakages of chromosomes) aberrations in
vivo[5]. Another considerable potential for novel hydrazide base chemotherapeutics is in the area of cancer
treatment. Significant cytotoxic activity against ovarian
cancer is noted for hydrazide based compounds[6]. In
addition, hydrazide based drugs have shown remarkable anticancer activity toward hormone-dependent and
hormone-independent human cancer cells[7]. Various hydrazide based drugs have demonstrated cytotoxicity
against drug-resistant cancer cell lines in combination
therapy[8].
Other studies have shown that salicylhydrazide
compounds demonstrate potent anti-cancer activity
against human cancer cell lines derived from different
origins[9]. The diversified efficacy of hydrazide based
drugs forecasts continued application in clinical arenas. Hydrazides have been studied as potential anti-

radiation drugs[10]. A benzoic acid hydrazide transferring tagged drug was utilized as target-carrier for studies of human breast cancer[11]. Novel medications that
are hydrazide based are being studied for clinical treatment of excessive fluid retention[12]. In addition, sulfur
based hydrazides have been studied for clinical nutritional modulation and control[13]. These applications
strongly support the necessity of having accurate and
sensitive means to detect and quantify hydrazide based
chemotherapeutics. This work present a rapid spot
test, qualitative colorimetric assay, and a sensitive
spectrophotometric methodology to ascertain hydrazide based drugs.
EXPERIMENTAL
Reagents and instruments
All reagents utilized for this study were supplied by
Sigma-Aldrich (P.O.Box 2060, Milwaukee WI, USA).
Gibb’s reagent (2,6-dichloroquinone-4-chloroimine)
was acquired through Sigma-Aldrich and was stored
dry until use at -10C. Organic solvents such as acetone was stored in airtight containers over molecular
sieves to remove water. All spectrophotometric measurements were made by Milton Roy Spectronic 21D
using UV/Visible glass cuvettes.
Colorimetric assay methodology
The mixture containing Gibb’s reagent 2,6dichloroquinone-4-chloroimine is made immediately
before use, kept at room temperature, and made fresh
before each application. An amount of 14 milligrams
2,6-dichloroquinone-4-chloroimine is dissolved into
14.0 milliliters of acetone. Into a reaction tube is placed
100 microliters of water, 100 microliters acetone, followed by 60 microliters of prepared Gibb’s reagent
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Figure 3 : The determination of hydrazide class of pharmaceuticals can be accomplished by colorimetric response method
which provides a qualitative value of concentration. Shown here are results of this determination from Plate A: Blank-no drug,
Test sample at 4 milligrams, and known control at 5 milligrams. By comparison to the 5 milligram control, the test sample can
be estimated at about 4 milligrams. Similarly Plat B: Blank-no drug, with known controls at 1 milligram and 5 milligram
permit estimation of unknown sample at 4 milligrams. Similarly Plate C: Blank-no drug, known controls at 3 milligrams and
10 milligrams drug permit assay of test sample at 4 milligrams.
Blank

microliters of 6 molar NH4OH will produce the positive brownish-yellow or a negative dark green-yellow
color response.
Assay by spectrophotometer
The spectrophotometric assay of hydrazide pharmaceuticals is accomplished at wavelength 970nm using UV/Visible glass cuvettes with a Spectronic 21D
instrument. Test samples to be assayed by spectrometer are first dissolved into acetone previously dried
over molecular sieves. A “blank” is prepared using acetone dried over molecular sieves. The pharmaceutical
Blank
A
B
drug samples are dissolved into acetone prior to solu128.2g/mL
359.0g/mL
bilizing into the reaction mixture. Preparation of the
Assay of hydrazide drugs
Figure 4 : For spectrophotometric assay of hydrazide drugs Gibb’s reagent is similar to that of colorimetric assay
the reaction of Gibb’s reagent with hydrazide is quantitative. (see above). All standards (utilizing semicarbazideHCl)
Shown is the colorimetric response for the Blank (Gibb’s re- and pharmaceuticals are prepared similarly. Into three
agent plus NH4OH). This method is highly sensitive, demonmilliliters of acetone is placed an amount of 500 microstrated by example samples determined to be (A) 128.2 micrograms per milliliter and (B) 359.0 micrograms per milliliter. liters acetone solution of previously dissolved pharmaceutical drug, followed by 350 microliters of Gibb’s
mixture, and finally 10 microliters of 6 molar NH4OH
prepared in water. Color reaction begins immediately regent mixture, and 50 microliters of 6 molar NH4OH.
and is followed by comparison of test samples to ap- Fifteen minutes is allowed for optimum colorimetric propropriate controls of known hydrazide group concen- duction, then read standards and test samples at 970nm
tration. For this study, semicarbazideHCl was utilized using dried acetone for adjusting for zero absorbance.
and demonstrated consistent and strong color response.
RESULTS & DISCUSSION
Rapid spot test
Into 200 microliters of prepared Gibb’s reagent (see
above for preparation) is added an equal volume of
test drug dissolved into acetone. The addition of 20
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Gibbs reagent with NH4OH and hydrazide pharmaceutical
Figure 5 : The absorbance spectra for Gibb’s reagent in NH4OH
and hydrazide complex formed upon reaction with Gibb’s reagent is shown from 370nm to 1000nm. The absorbance
maxima at 970nm from the hydrazide complex is used for
spectrophotometric determination of pharmaceuticals.

health. Having the hydrazide (-C(=O)NHNH2) functional group facilitates a drug structure having a diverse
biological activity. Methods to determine the presence
and amounts of these drugs would be valuable for clinical settings as well as industrial and health care facilities. Gibb’s reagent (2,6-dichloroquinone-4-chloroimine) will react with, and assay, many para substituted
phenolic based compounds[14-16]. Because of the tremendous importance of hydrazide based anti-tuberculosis pharmaceuticals (such as the first-line drug isoniazid) for treating and prevention of tuberculosis an
efficient methodology for detection and assay would
be beneficial. A rapid spot test, colorimetric assay, and
spectrophotometric determination of hydrazide based
anti-tuberculosis agents is presented in this work. Several hydrazide compounds were synthesized by a microwave methodology demonstrated previously[17], presented in figure 1, and were utilized in this work to establish the efficiency of hydrazide drug determination
by utilizing Gibb’s reagent 2,6-dichloroquinone-4chloroimine. Drugs A, B, C, and D (Figure 1) each
have a single hydrazide functional group present (indicated by inset rectangle). Drugs A, B, C, and D have
been shown in previous work to be effective inhibitors
of Tuberculosis proliferation[17]. In addition to the hydrazide moiety these four drugs have at least one aromatic ring. The structure of drugs A, B, and C have a
bromine substituent on the aromatic ring which is shifted
from ortho, to meta, and para position, respectively.

Determination of hydrazide drugs
Figure 6 : A standard curve for hydrazide based pharmaceuticals shows accuracy and sensitivity to 115 micrograms per
milliliter.

The parent structure of drug D is ciprofloxacin which is
a second generation fluoroquinolone broad-spectrum
antibacterial that inhibits bacterial growth by interfering
with enzymes necessary for DNA unwind and duplication[18]. In addition to these four drugs the compound
semicarbazide was utilized to establish a sensitive spectrophotometric absorbance assay. All reagents are made
fresh before use. Many inorganic and organic compounds were shown to be non-interfering for these colorimetric methods. These compounds are presented in
TABLE 1, and include NaBr, NaCl, MgSO 4 ,
NaH2PO4, salicylic acid, itaconic acid, benzoin, adipic
acid, trans-cinnamic acid, DL-mandelic acid, and paminobenzoic acid as representative assemblage. For
quick identification of hydrazide based pharmaceuticals a colorimetric presumptive test or rapid spot test
has several assets. Notably this type of test are viewed
as: 1) rapid, 2) simple, 3) facile interpretation, and 4)
mobile. An example of a rapid spot test for hydrazide
based drugs is presented in figure 2. The ‘negative’ event
is a very dark green colorized mixture that is highly differentiated from a ‘positive’ event that can be described
as a yellow-brown or gold outcome. These only two
possible results are contrasted and easily distinguishable. This example shows results for only 2 milligrams
of drug. The assay for hydrazide class of pharmaceuticals can be accomplished by a colorimetric response
method which provides a qualitative value of concentration. Several examples of this style is presented in
figure 3. Shown are outcome of this qualitative assay in
Plates A, B, and C. Outcome for Plate A: Blank-no
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TABLE 1 : Compounds not interfering with assay.

ceutics. In the range from 370nm to 1000nm the Gibb’s
reagent plus NH4OH produces a dark blue mixture that
conflicts with the outcome of the Gibb’s reagent plus
hydrazide group. Only in the wavelength range from
930nm to 1000nm does the Gibb’s reagent plus hydrazide drug generate an overwhelming absorbance
compared to the Gibb’s reagent plus NH4OH side reaction. Therefore the wavelength of 970nm is utilized
for the spectrophotometric quantitative analysis. The
final molar absorptivity () is calculated to be 25.32
Liters/(molecm) at 970nm. A representative standard
curve is visualized in figure 6. Where the standard curve
for hydrazide based pharmaceuticals shows accuracy
and sensitivity to 115 micrograms per milliliter. Linearity is extremely high rendering a Pearson correlation
drug (negative control), a Test sample at 4 milligrams, constant r of 0.9841. The equation of this particular
and a known positive control at 5 milligrams. By in- line becomes: y = 0.0001x + 0.015. The percent respection using the 5 milligram control, the test sample covery for pharmaceutical analyte is extremely high from
can be estimated at about 4 milligrams. Similarly for 95% to 105%. The R2, coefficient of determination for
Plate B: Blank-no drug (negative control), positive con- this data is 0.9685, indicating that 96.85% of all varitrols at 1 milligram and 5 milligram permit estimation of ance in the data is accounted for by the equation. Clearly
the unknown sample at 4 milligrams. Similarly with Plate the identification of hydrazide based pharmaceuticals
C: Blank-no drug (negative control), known controls at can by done accurately and consistently by reaction
3 milligrams and 10 milligrams drug permit assay of the with Gibb’s reagent. The methodologies presented in
test sample at 4 milligrams. Likewise to the rapid spot this study will find considerable efficacy for environtest this approach is simple yet produces outcomes that mental related applications where it is necessary to idenare highly distinguishable. A spectrophotometric assay tify and quantify drugs that bear the hydrazide funcfor hydrazide drugs also demonstrates that the chemi- tional group.
cal reaction of Gibb’s reagent with hydrazide functional
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